Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Chronic Obstructive Pulmonary Disease and Risk of Mortality in Patients with Venous Thromboembolism-The Tromsø Study.

Børvik T, Brækkan SK, Evensen LH, Brodin EE, Morelli VM, Melbye H, Hansen JB.

Thromb Haemost. 2019 Dec 30. doi: 10.1055/s-0039-3400744. [Epub ahead of print]

PMID:
31887782
2.

Genetic variation of platelet glycoprotein VI and the risk of venous thromboembolism.

Skille H, Paulsen B, Hveem K, Gabrielsen ME, Brumpton B, Hindberg K, Gran OV, Rosendaal FR, Brækkan SK, Hansen JB.

Haematologica. 2019 Nov 7. pii: haematol.2019.231225. doi: 10.3324/haematol.2019.231225. [Epub ahead of print]

3.

Dietary Intake of Marine Polyunsaturated n-3 Fatty Acids and Risk of Recurrent Venous Thromboembolism.

Isaksen T, Evensen LH, Brækkan SK, Hansen JB.

Thromb Haemost. 2019 Dec;119(12):2053-2063. doi: 10.1055/s-0039-1697663. Epub 2019 Oct 28.

PMID:
31659738
4.

Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).

Timp JF, Braekkan SK, Lijfering WM, van Hylckama Vlieg A, Hansen JB, Rosendaal FR, le Cessie S, Cannegieter SC.

PLoS Med. 2019 Oct 11;16(10):e1002883. doi: 10.1371/journal.pmed.1002883. eCollection 2019 Oct.

5.

Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism.

Paulsen B, Skille H, Smith EN, Hveem K, Gabrielsen ME, Brækkan SK, Rosendaal FR, Frazer KA, Gran OV, Hansen JB.

Haematologica. 2019 Oct 3. pii: haematol.2019.224279. doi: 10.3324/haematol.2019.224279. [Epub ahead of print]

6.

Cardiorespiratory fitness and future risk of venous thromboembolism.

Evensen LH, Isaksen T, Braekkan SK, Hansen JB.

J Thromb Haemost. 2019 Dec;17(12):2160-2168. doi: 10.1111/jth.14619. Epub 2019 Sep 17.

PMID:
31448518
7.

Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism.

Lindström S, Wang L, Smith EN, Gordon W, van Hylckama Vlieg A, de Andrade M, Brody JA, Pattee JW, Haessler J, Brumpton BM, Chasman DI, Suchon P, Chen MH, Turman C, Germain M, Wiggins KL, MacDonald J, Braekkan SK, Armasu SM, Pankratz N, Jackson RD, Nielsen JB, Giulianini F, Puurunen MK, Ibrahim M, Heckbert SR, Damrauer SM, Natarajan P, Klarin D; Million Veteran Program, de Vries PS, Sabater-Lleal M, Huffman JE; CHARGE Hemostasis Working Group, Bammler TK, Frazer KA, McCauley BM, Taylor K, Pankow JS, Reiner AP, Gabrielsen ME, Deleuze JF, O'Donnell CJ, Kim J, McKnight B, Kraft P, Hansen JB, Rosendaal FR, Heit JA, Psaty BM, Tang W, Kooperberg C, Hveem K, Ridker PM, Morange PE, Johnson AD, Kabrhel C, Trégouët DA, Smith NL.

Blood. 2019 Nov 7;134(19):1645-1657. doi: 10.1182/blood.2019000435.

PMID:
31420334
8.

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding.

Johnsen HS, Hindberg K, Bjøri E, Brodin EE, Brækkan SK, Morelli VM, Hansen JB.

TH Open. 2019 Mar 25;3(1):e77-e84. doi: 10.1055/s-0039-1683395. eCollection 2019 Jan.

9.

The Role of Stroke as a Trigger for Incident Venous Thromboembolism: Results from a Population-based Case-Crossover Study.

Morelli VM, Sejrup JK, Småbrekke B, Rinde LB, Grimnes G, Isaksen T, Hansen JB, Hindberg K, Brækkan SK.

TH Open. 2019 Feb 22;3(1):e50-e57. doi: 10.1055/s-0039-1681020. eCollection 2019 Jan.

10.

Impact of Chronic Inflammation, Assessed by hs-CRP, on the Association between Red Cell Distribution Width and Arterial Cardiovascular Disease: The Tromsø Study.

Lappegård J, Ellingsen TS, Hindberg K, Mathiesen EB, Njølstad I, Wilsgaard T, Løchen ML, Brækkan SK, Hansen JB.

TH Open. 2018 May 16;2(2):e182-e189. doi: 10.1055/s-0038-1651523. eCollection 2018 Apr.

11.

Plasma levels of mannose-binding lectin and future risk of venous thromboembolism.

Liang RA, Høiland II, Ueland T, Aukrust P, Snir O, Hindberg K, Braekkan SK, Garred P, Mollnes TE, Hansen JB.

J Thromb Haemost. 2019 Oct;17(10):1661-1669. doi: 10.1111/jth.14539. Epub 2019 Jul 1.

PMID:
31220397
12.

Myocardial Infarction as a Transient Risk Factor for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study.

Sejrup JK, Børvik T, Grimnes G, Isaksen T, Hindberg K, Hansen JB, Morelli VM, Brækkan SK.

Thromb Haemost. 2019 Aug;119(8):1358-1364. doi: 10.1055/s-0039-1692176. Epub 2019 Jun 16.

PMID:
31203579
13.

Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism.

Småbrekke B, Rinde LB, Evensen LH, Morelli VM, Hveem K, Gabrielsen ME, Njølstad I, Mathiesen EB, Rosendaal FR, Braekkan SK, Hansen JB.

J Thromb Haemost. 2019 Aug;17(8):1363-1371. doi: 10.1111/jth.14493. Epub 2019 Jun 7.

PMID:
31124268
14.

Physical activity and risk of recurrence and mortality after incident venous thromboembolism.

Evensen LH, Isaksen T, Braekkan SK, Hansen JB.

J Thromb Haemost. 2019 Jun;17(6):901-911. doi: 10.1111/jth.14449. Epub 2019 May 11.

PMID:
30985982
15.

Complement activation assessed by the plasma terminal complement complex and future risk of venous thromboembolism.

Høiland II, Liang RA, Braekkan SK, Pettersen K, Ludviksen JK, Latysheva N, Snir O, Ueland T, Hindberg K, Mollnes TE, Hansen JB.

J Thromb Haemost. 2019 Jun;17(6):934-943. doi: 10.1111/jth.14438. Epub 2019 May 13.

PMID:
30920726
16.

Hospitalization as a trigger for venous thromboembolism - Results from a population-based case-crossover study.

Bjøri E, Johnsen HS, Hansen JB, Brækkan SK.

Thromb Res. 2019 Apr;176:115-119. doi: 10.1016/j.thromres.2019.02.024. Epub 2019 Feb 21.

PMID:
30822715
17.

Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study.

Rinde LB, Morelli VM, Småbrekke B, Mathiesen EB, Løchen ML, Njølstad I, Wilsgaard T, Smith E, Rosendaal FR, Frazer KA, Braekkan SK, Hansen JB.

J Thromb Haemost. 2019 May;17(5):749-758. doi: 10.1111/jth.14410. Epub 2019 Mar 12.

PMID:
30773804
18.

A large-scale exome array analysis of venous thromboembolism.

Lindström S, Brody JA, Turman C, Germain M, Bartz TM, Smith EN, Chen MH, Puurunen M, Chasman D, Hassler J, Pankratz N, Basu S, Guan W, Gyorgy B, Ibrahim M, Empana JP, Olaso R, Jackson R, Braekkan SK, McKnight B, Deleuze JF, O'Donnell CJ, Jouven X, Frazer KA, Psaty BM, Wiggins KL, Taylor K, Reiner AP, Heckbert SR, Kooperberg C, Ridker P, Hansen JB, Tang W, Johnson AD, Morange PE, Trégouët DA, Kraft P, Smith NL, Kabrhel C; INVENT Consortium.

Genet Epidemiol. 2019 Jun;43(4):449-457. doi: 10.1002/gepi.22187. Epub 2019 Jan 19.

PMID:
30659681
19.

Dietary intake of marine n-3 polyunsaturated fatty acids and future risk of venous thromboembolism.

Isaksen T, Evensen LH, Johnsen SH, Jacobsen BK, Hindberg K, Brækkan SK, Hansen JB.

Res Pract Thromb Haemost. 2018 Dec 13;3(1):59-69. doi: 10.1002/rth2.12168. eCollection 2019 Jan.

20.

Impact of preanalytical conditions on plasma concentration and size distribution of extracellular vesicles using Nanoparticle Tracking Analysis.

Jamaly S, Ramberg C, Olsen R, Latysheva N, Webster P, Sovershaev T, Brækkan SK, Hansen JB.

Sci Rep. 2018 Nov 21;8(1):17216. doi: 10.1038/s41598-018-35401-8.

21.

Regular Physical Activity and Risk of Venous Thromboembolism.

Evensen LH, Brækkan SK, Hansen JB.

Semin Thromb Hemost. 2018 Nov;44(8):765-779. doi: 10.1055/s-0038-1673636. Epub 2018 Oct 4. Review.

PMID:
30286501
22.

Repeated assessments of physical activity and risk of incident venous thromboembolism.

Evensen LH, Isaksen T, Hindberg K, Braekkan SK, Hansen JB.

J Thromb Haemost. 2018 Nov;16(11):2208-2217. doi: 10.1111/jth.14287. Epub 2018 Oct 9.

PMID:
30191665
23.

Substantial recurrence risk after venous thromboembolism provoked by minor risk factors.

Braekkan SK, Hansen JB.

J Thromb Haemost. 2018 Sep;16(9):1671-1673. doi: 10.1111/jth.14239. Epub 2018 Aug 9. Review. No abstract available.

PMID:
30094929
24.

The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer.

Ellingsen TS, Lappegård J, Skjelbakken T, Mathiesen EB, Njølstad I, Brækkan SK, Hansen JB.

Res Pract Thromb Haemost. 2018 Jan 19;2(2):327-333. doi: 10.1002/rth2.12073. eCollection 2018 Apr.

25.

Acute infection as a trigger for incident venous thromboembolism: Results from a population-based case-crossover study.

Grimnes G, Isaksen T, Tichelaar YIGV, Brækkan SK, Hansen JB.

Res Pract Thromb Haemost. 2017 Dec 21;2(1):85-92. doi: 10.1002/rth2.12065. eCollection 2018 Jan.

26.

Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomics.

Jensen SB, Hindberg K, Solomon T, Smith EN, Lapek JD Jr, Gonzalez DJ, Latysheva N, Frazer KA, Braekkan SK, Hansen JB.

J Thromb Haemost. 2018 Sep;16(9):1763-1774. doi: 10.1111/jth.14220. Epub 2018 Aug 6.

27.

Elevated plasma levels of P-selectin glycoprotein ligand-1-positive microvesicles in patients with unprovoked venous thromboembolism.

Jamaly S, Basavaraj MG, Starikova I, Olsen R, Braekkan SK, Hansen JB.

J Thromb Haemost. 2018 May 31. doi: 10.1111/jth.14162. [Epub ahead of print]

PMID:
29851269
28.

Plasma hepcidin is associated with future risk of venous thromboembolism.

Ellingsen TS, Lappegård J, Ueland T, Aukrust P, Brækkan SK, Hansen JB.

Blood Adv. 2018 Jun 12;2(11):1191-1197. doi: 10.1182/bloodadvances.2018018465.

29.

Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study.

Johnsen SH, Jacobsen BK, Brækkan SK, Hansen JB, Mathiesen EB.

Nutr J. 2018 May 25;17(1):56. doi: 10.1186/s12937-018-0364-8.

30.

Prothrombotic genotypes and risk of venous thromboembolism in cancer.

Gran OV, Brækkan SK, Hansen JB.

Thromb Res. 2018 Apr;164 Suppl 1:S12-S18. doi: 10.1016/j.thromres.2017.12.025.

PMID:
29703469
31.

Impact of time since diagnosis and mortality rate on cancer-associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort.

Blix K, Gran OV, Severinsen MT, Cannegieter SC, Jensvoll H, Overvad K, Hammerstrøm J, Tjønneland A, Naess IA, Braekkan SK, Rosendaal FR, Kristensen SR, Hansen JB.

J Thromb Haemost. 2018 Jul;16(7):1327-1335. doi: 10.1111/jth.14130. Epub 2018 May 27.

PMID:
29691978
32.

C-reactive protein and risk of venous thromboembolism: results from a population-based case-crossover study.

Grimnes G, Isaksen T, Tichelaar YIGV, Brox J, Brækkan SK, Hansen JB.

Haematologica. 2018 Jul;103(7):1245-1250. doi: 10.3324/haematol.2017.186957. Epub 2018 Apr 19.

33.

Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort.

Gade IL, Brækkan SK, Næss IA, Hansen JB, Cannegieter SC, Rosendaal FR, Overvad K, Hindberg K, Hammerstrøm J, Gran OV, Tjønneland A, Severinsen MT, Kristensen SR.

TH Open. 2018 Apr 6;2(2):e131-e138. doi: 10.1055/s-0038-1641678. eCollection 2018 Apr.

34.

Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.

Hald EM, Rinde LB, Løchen ML, Mathiesen EB, Wilsgaard T, Njølstad I, Brækkan SK, Hansen JB.

J Am Heart Assoc. 2018 Jan 29;7(3). pii: e006502. doi: 10.1161/JAHA.117.006502.

35.

Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study.

Horvei LD, Braekkan SK, Smith EN, Solomon T, Hindberg K, Frazer KA, Rosendaal FR, Hansen JB.

J Thromb Haemost. 2018 Jan;16(1):83-89. doi: 10.1111/jth.13892. Epub 2017 Nov 27.

36.

Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study.

Småbrekke B, Rinde LB, Hald EM, Njølstad I, Mathiesen EB, Johnsen SH, Hansen JB, Braekkan SK, Lijfering WM.

J Thromb Haemost. 2017 Dec;15(12):2344-2351. doi: 10.1111/jth.13858. Epub 2017 Oct 27.

37.

Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromsø Study.

Lind C, Småbrekke B, Rinde LB, Hindberg K, Mathiesen EB, Johnsen SH, Arntzen KA, Njølstad I, Lijfering W, Brækkan SK, Hansen JB.

TH Open. 2017 Jun 28;1(1):e66-e72. doi: 10.1055/s-0037-1603983. eCollection 2017 Jun.

38.

Serum osteoprotegerin and renal function in the general population: the Tromsø Study.

Vik A, Brodin EE, Mathiesen EB, Brox J, Jørgensen L, Njølstad I, Brækkan SK, Hansen JB.

Clin Kidney J. 2017 Feb;10(1):38-44. doi: 10.1093/ckj/sfw095. Epub 2016 Oct 3.

39.

The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort.

Gade IL, Braekkan SK, Naess IA, Hansen JB, Cannegieter SC, Overvad K, Jensvoll H, Hammerstrøm J, Blix K, Tjønneland A, Kristensen SR, Severinsen MT.

J Thromb Haemost. 2017 Aug;15(8):1567-1575. doi: 10.1111/jth.13752. Epub 2017 Jul 11.

40.

Statin use and risk of recurrent venous thrombosis: results from the MEGA follow-up study.

Brækkan SK, Caram-Deelder C, Siegerink B, van Hylckama Vlieg A, le Cessie S, Rosendaal FR, Cannegieter SC, Lijfering WM.

Res Pract Thromb Haemost. 2017 May 25;1(1):112-119. doi: 10.1002/rth2.12003. eCollection 2017 Jul.

41.

Occult cancer-related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism.

Gran OV, Braekkan SK, Paulsen B, Skille H, Rosendaal FR, Hansen JB.

J Thromb Haemost. 2017 Jul;15(7):1361-1367. doi: 10.1111/jth.13714. Epub 2017 May 28.

42.

Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population.

Arshad N, Isaksen T, Hansen JB, Brækkan SK.

Eur J Epidemiol. 2017 Apr;32(4):299-305. doi: 10.1007/s10654-017-0238-y. Epub 2017 Mar 17.

PMID:
28314981
43.

Associations between serum levels of calcium, parathyroid hormone and future risk of venous thromboembolism: the Tromsø study.

Lerstad G, Brodin EE, Svartberg J, Jorde R, Brox J, Brækkan SK, Hansen JB.

Eur J Endocrinol. 2017 May;176(5):625-634. doi: 10.1530/EJE-16-1037. Epub 2017 Feb 28.

PMID:
28246149
44.

Antibiotic use as a marker of acute infection and risk of first and recurrent venous thrombosis.

Timp JF, Cannegieter SC, Tichelaar V, Braekkan SK, Rosendaal FR, le Cessie S, Lijfering WM.

Br J Haematol. 2017 Mar;176(6):961-970. doi: 10.1111/bjh.14551. Epub 2017 Feb 17.

PMID:
28211044
45.

Myocardial infarction and future risk of cancer in the general population-the Tromsø Study.

Rinde LB, Småbrekke B, Hald EM, Brodin EE, Njølstad I, Mathiesen EB, Løchen ML, Wilsgaard T, Brækkan SK, Vik A, Hansen JB.

Eur J Epidemiol. 2017 Mar;32(3):193-201. doi: 10.1007/s10654-017-0231-5. Epub 2017 Feb 7.

PMID:
28176141
46.

D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.

Bjøri E, Johnsen HS, Hansen JB, Braekkan SK.

J Thromb Haemost. 2017 May;15(5):917-924. doi: 10.1111/jth.13648. Epub 2017 Feb 24.

47.

Weight Change and Risk of Venous Thromboembolism: The Tromsø Study.

Horvei LD, Brækkan SK, Hansen JB.

PLoS One. 2016 Dec 20;11(12):e0168878. doi: 10.1371/journal.pone.0168878. eCollection 2016.

48.

Recurrence and mortality after first venous thromboembolism in a large population-based cohort.

Arshad N, Bjøri E, Hindberg K, Isaksen T, Hansen JB, Braekkan SK.

J Thromb Haemost. 2017 Feb;15(2):295-303. doi: 10.1111/jth.13587. Epub 2017 Feb 6.

49.

Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.

Mahmoodi BK, Cushman M, Anne Næss I, Allison MA, Bos WJ, Brækkan SK, Cannegieter SC, Gansevoort RT, Gona PN, Hammerstrøm J, Hansen JB, Heckbert S, Holst AG, Lakoski SG, Lutsey PL, Manson JE, Martin LW, Matsushita K, Meijer K, Overvad K, Prescott E, Puurunen M, Rossouw JE, Sang Y, Severinsen MT, Ten Berg J, Folsom AR, Zakai NA.

Circulation. 2017 Jan 3;135(1):7-16. doi: 10.1161/CIRCULATIONAHA.116.024507. Epub 2016 Nov 9. Erratum in: Circulation. 2017 Mar 21;135(12 ):e788.

50.

Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.

Rinde LB, Småbrekke B, Mathiesen EB, Løchen ML, Njølstad I, Hald EM, Wilsgaard T, Brækkan SK, Hansen JB.

J Am Heart Assoc. 2016 Nov 7;5(11). pii: e004311.

Supplemental Content

Loading ...
Support Center